CLOMIPHENE CITRATE AND NEURAL-TUBE DEFECTS - A POOLED ANALYSIS OF CONTROLLED EPIDEMIOLOGIC STUDIES AND RECOMMENDATIONS FOR FUTURE STUDIES

Citation
S. Greenland et Dl. Ackerman, CLOMIPHENE CITRATE AND NEURAL-TUBE DEFECTS - A POOLED ANALYSIS OF CONTROLLED EPIDEMIOLOGIC STUDIES AND RECOMMENDATIONS FOR FUTURE STUDIES, Fertility and sterility, 64(5), 1995, pp. 936-941
Citations number
39
Categorie Soggetti
Obsetric & Gynecology
Journal title
ISSN journal
00150282
Volume
64
Issue
5
Year of publication
1995
Pages
936 - 941
Database
ISI
SICI code
0015-0282(1995)64:5<936:CCAND->2.0.ZU;2-3
Abstract
Objective: To estimate the degree to which neural tube defects (NTDs) are associated with periconceptional clomiphene citrate (CC) exposure in controlled epidemiologic studies, to investigate the consistency of study findings with respect to this association, and to identify key problems that future studies should address. Design: Pooled analysis o f 10 epidemiologic studies. Settings: Hospitals and clinics. Patients: Women undergoing treatment for infertility. Interventions: Oral admin istration of CC. Main Outcome Measure: Prevalence ratio for NTDs. Resu lts: Ten controlled epidemiologic studies were identified that supplie d sufficient data on CC and NTDs for inclusion. The estimated ratio of NTD prevalence among CC-exposed versus unexposed pregnancies ranged f rom 0.55 to 5.73 among the studies, but the variation was compatible w ith random fluctuation. The estimated summary prevalence ratio was 1.0 8, with 95% confidence limits of 0.76 and 1.51. Conclusion: This analy sis indicates that an elevation in NTD risk due to CC cannot be ruled out, but any such elevation seems likely to be less than twofold, and there may be no elevation at all. Future studies should be designed to avoid several methodological problems not addressed in studies to dat e.